Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy
PaperCitations, authors & open-access status
PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 91 citations, 2020 year and diamond oa status.
91
Citations
2020
Year
diamond
OA Status